NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,003 | -5.0% | 34,669 | -2.5% | 0.00% | – |
| Q2 2023 | $264,077 | -67.3% | 35,542 | -69.5% | 0.00% | – |
| Q1 2023 | $807,830 | +2.8% | 116,570 | +52.5% | 0.00% | – |
| Q4 2022 | $785,886 | -63.4% | 76,448 | -35.3% | 0.00% | -100.0% |
| Q3 2022 | $2,149,000 | -63.4% | 118,136 | +3.5% | 0.00% | -50.0% |
| Q2 2022 | $5,867,000 | -34.5% | 114,099 | -6.2% | 0.00% | 0.0% |
| Q1 2022 | $8,963,000 | -64.5% | 121,685 | -31.0% | 0.00% | -66.7% |
| Q4 2021 | $25,246,000 | +100.6% | 176,457 | +190.7% | 0.01% | +100.0% |
| Q3 2021 | $12,584,000 | +17.0% | 60,696 | +19.8% | 0.00% | 0.0% |
| Q2 2021 | $10,757,000 | -49.5% | 50,662 | -56.9% | 0.00% | -50.0% |
| Q1 2021 | $21,310,000 | +36.1% | 117,531 | -16.3% | 0.01% | +20.0% |
| Q4 2020 | $15,660,000 | -15.1% | 140,428 | -17.5% | 0.01% | -16.7% |
| Q3 2020 | $18,435,000 | -44.6% | 170,137 | -57.4% | 0.01% | -50.0% |
| Q2 2020 | $33,267,000 | +368.7% | 399,127 | -23.6% | 0.01% | +300.0% |
| Q1 2020 | $7,097,000 | – | 522,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |